AZ Prioritizes Protection With COVID-19 Mask Donations
9 Million Donated With Italy First Recipient
AstraZeneca is aiding the effort to protect healthcare workers against coronavirus with the necessary equipment . It is also set to unveil plans for new diagnostic testing and advancing development of a monoclonal antibody treatment to prevent COVID-19.
You may also be interested in...
The pharma giants are joining forces to help the UK reach its ambitious target of testing 100,000 people a day for coronavirus by the end of April.
The diagnostics tie-up with GSK on testing is a near-term move to help the UK get back to normality, the drug major's biopharmaceuticals R&D boss tells Scrip. AstraZeneca's main focus is to develop monoclonal antibodies to tackle 'wave two' of the coronavirus.
Speaking to Scrip, Steven Baert, chief people and organization officer at Novartis, said that a company’s response to coronavirus reveals its real identity and will shape its future.